<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 12.4: Targeted Microbiome Interventions: Akkermansia & SCFAs</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #065f46 0%, #059669 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 38px;
            font-weight: 700;
            margin-bottom: 8px;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f0fdf4;
            color: #059669;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #10B981;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            margin-bottom: 10px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 12: Advanced Longevity Deep Dives</p>
            <h1 class="lesson-title">Lesson 12.4: Targeted Microbiome Interventions: Akkermansia & SCFAs</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Longevity Mastery Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Akkermansia: The Mucosal Guardian</a></li>
                <li><a href="#section2"><span class="section-num">2</span>SCFAs as Epigenetic Modulators</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Precision Prebiotic Strategies</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Urolithin A & Mitophagy Axis</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Restoration & Diversity Protocols</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Application & A.G.E.L.E.S.S. Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the clinical significance of <i>Akkermansia muciniphila</i> in metabolic health and gut barrier integrity.</li>
                <li>Analyze the biochemical pathways of Short-Chain Fatty Acids (SCFAs) as HDAC inhibitors and longevity gene regulators.</li>
                <li>Design precision prebiotic protocols tailored to specific microbial deficiencies and client phenotypes.</li>
                <li>Understand the role of postbiotics, specifically Urolithin A, in triggering mitophagy and cellular renewal.</li>
                <li>Implement evidence-based restoration strategies for the microbiome following antibiotic use or chronic dysbiosis.</li>
            </ul>
        </div>

        <h2 id="section1">1. Akkermansia muciniphila: The Keystone of Metabolic Longevity</h2>
        <p>In previous lessons, we discussed the broad concept of microbiome diversity. Now, we narrow our focus to the "VIPs" of the gut. <span class="highlight">Akkermansia muciniphila</span> is a gram-negative, anaerobic bacterium that resides in the mucus layer of the large intestine. Unlike most bacteria that rely on dietary fiber, <i>Akkermansia</i> is a "mucus-eater"â€”it thrives on the glycans found in the intestinal mucus layer.</p>

        <p>This seemingly destructive behavior is actually a critical feedback loop. By consuming the older mucus, <i>Akkermansia</i> stimulates goblet cells to produce fresh, new mucus, thereby <span class="highlight">thickening the gut barrier</span>. A thin mucus layer is a hallmark of aging and a primary driver of "leaky gut" and systemic inflammaging.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">1-5%</span>
                    <span class="stat-label">Abundance in Healthy Adults</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">42%</span>
                    <span class="stat-label">Reduction in Obese Phenotypes</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">30%</span>
                    <span class="stat-label">Increase in Insulin Sensitivity</span>
                </div>
            </div>
        </div>

        <p>Clinical research, most notably by Depommier et al. (2019), demonstrated that daily supplementation with <i>Akkermansia</i> (specifically the pasteurized form) for three months significantly improved metabolic parameters, including insulin sensitivity and total cholesterol, while reducing markers of liver inflammation and body weight.</p>

        <h2 id="section2">2. SCFAs as Epigenetic Modulators: The Butyrate Connection</h2>
        <p>Short-Chain Fatty Acids (SCFAs)â€”primarily Acetate, Propionate, and Butyrateâ€”are the metabolic byproducts of bacterial fermentation of undigested carbohydrates. While they serve as local energy sources for colonocytes, their systemic effects are far more profound, acting as potent <span class="highlight">epigenetic signaling molecules</span>.</p>

        <p>Butyrate, in particular, functions as a <span class="highlight">Histone Deacetylase (HDAC) inhibitor</span>. By inhibiting HDACs, butyrate allows DNA to remain in a "relaxed" state (euchromatin), facilitating the transcription of genes involved in:
        <ul class="content-list">
            <li><b>Regulatory T-cell (Treg) differentiation:</b> Suppressing systemic inflammation.</li>
            <li><b>FOXP3 expression:</b> Enhancing immune tolerance.</li>
            <li><b>Mitochondrial function:</b> Upregulating PGC-1Î± to stimulate mitochondrial biogenesis.</li>
            <li><b>BDNF production:</b> Promoting neuroplasticity via the gut-brain axis.</li>
        </ul>
        </p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>SCFA Type</th>
                        <th>Primary Source</th>
                        <th>Longevity Mechanism</th>
                        <th>Target Tissue</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><b>Butyrate</b></td>
                        <td>Resistant Starch, Inulin</td>
                        <td>HDAC Inhibition, Gut Barrier Strength</td>
                        <td>Colon, Immune System, Brain</td>
                    </tr>
                    <tr>
                        <td><b>Propionate</b></td>
                        <td>Guar Gum, Beta-glucans</td>
                        <td>Gluconeogenesis Regulation, Satiety</td>
                        <td>Liver, Hypothalamus</td>
                    </tr>
                    <tr>
                        <td><b>Acetate</b></td>
                        <td>Cross-feeding (Bifido)</td>
                        <td>Lipid Metabolism, pH regulation</td>
                        <td>Peripheral Tissues</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Precision Prebiotic Supplementation</h2>
        <p>The "shotgun approach" to fiberâ€”simply telling a client to eat more vegetablesâ€”is often insufficient for longevity coaching. Precision longevity requires matching specific <span class="highlight">prebiotic substrates</span> to the desired microbial outcome. If a client's stool test shows low <i>Akkermansia</i>, high doses of generic psyllium husk may not be the answer.</p>

        <p>To specifically boost <i>Akkermansia</i> and SCFA production, we utilize:
        <ul class="content-list">
            <li><b>Polyphenols:</b> Ellagitannins (pomegranate), Anthocyanins (blackberries), and EGCG (green tea). <i>Akkermansia</i> thrives in the presence of these compounds.</li>
            <li><b>HMOs (Human Milk Oligosaccharides):</b> Specifically 2'-Fucosyllactose (2'-FL). While found in breast milk, supplemental versions are potent bifidogenic and <i>Akkermansia</i>-boosting agents in adults.</li>
            <li><b>Resistant Starch (Type 2 & 3):</b> Unripe bananas or cooked-and-cooled potatoes. These are the "gold standard" for increasing butyrate levels.</li>
        </ul>
        </p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Metabolic Rescue</p>
                    <p style="color: rgba(255,255,255,0.8); font-size: 13px; margin: 0;">Client: James, 54 | Goal: Reverse Pre-diabetes & Inflammaging</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">J</div>
                    <div class="patient-info">
                        <h4>James P. (54yo Male)</h4>
                        <p>HbA1c: 5.9%, hs-CRP: 3.2 mg/L, Low microbial diversity (GI-MAP results).</p>
                    </div>
                </div>
                <p><b>Intervention:</b> A 12-week precision protocol including 15g/day of partially hydrolyzed guar gum (PHGG), 500mg of standardized Pomegranate extract (ellagitannins), and 10^10 CFU of pasteurized <i>Akkermansia muciniphila</i>.</p>
                <p><b>Outcomes:</b>
                <ul>
                    <li>HbA1c dropped from 5.9% to 5.4% (normalization).</li>
                    <li>hs-CRP reduced by 45% (to 1.7 mg/L).</li>
                    <li>Significant increase in <i>Akkermansia</i> abundance (from 0.02% to 2.1% of total microbiome).</li>
                </ul>
                </p>
            </div>
        </div>

        <h2 id="section4">4. The Emergence of Postbiotics: Urolithin A & Mitophagy</h2>
        <p>A "Postbiotic" is defined as a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host. One of the most exciting breakthroughs in longevity science is <span class="highlight">Urolithin A</span>.</p>

        <p>Urolithin A is a metabolite produced by gut bacteria (including certain <i>Clostridium</i> species) from ellagitannins found in pomegranates and walnuts. However, research shows that <span class="highlight">only about 40% of the population</span> possesses the specific microbiome composition necessary to convert these precursors into therapeutic levels of Urolithin A.</p>

        <p><b>Mechanism of Action:</b> Urolithin A is a first-in-class natural compound that triggers <span class="highlight">mitophagy</span>â€”the selective recycling of damaged mitochondria. In a 2022 clinical trial published in <i>JAMA Network Open</i>, direct supplementation with Urolithin A (500mg - 1,000mg) was shown to improve muscle endurance and reduce pro-inflammatory cytokines, mimicking the effects of exercise in sedentary older adults.</p>

        <h2 id="section5">5. Restoration Protocols: Post-Antibiotic & Chronic Dysbiosis</h2>
        <p>Restoring a degraded microbiome is a cornerstone of the <b>"G" (Gut)</b> pillar in the A.G.E.L.E.S.S. Longevity Protocolâ„¢. When a client has undergone antibiotic treatment or years of a Western diet, the "Seed and Feed" approach must be systemic.</p>

        <h3>The 3-Phase Restoration Protocol:</h3>
        <p>
        <ol class="content-list">
            <li><b>Phase 1: The "Weed" Phase (Weeks 1-3):</b> Focus on reducing overgrowth of pathobionts using antimicrobial herbs (Berberine, Oregano oil) while supporting the mucosal lining with L-Glutamine and Zinc Carnosine.</li>
            <li><b>Phase 2: The "Seed" Phase (Weeks 4-8):</b> Introduction of keystone species. This includes high-potency multi-strain probiotics (Bifidobacterium and Lactobacillus) and specifically <i>Akkermansia</i>.</li>
            <li><b>Phase 3: The "Feed" Phase (Ongoing):</b> Shifting to precision prebiotics (FOS, GOS, polyphenols) to sustain the newly established colonies and maximize SCFA production.</li>
        </ol>
        </p>

        <h2 id="section6">6. Clinical Application: Integrating into the A.G.E.L.E.S.S. Protocolâ„¢</h2>
        <p>As a Longevity Coach, your role is to bridge the gap between "gut health" and "longevity science." Use the following framework when consulting with clients:</p>

        <div class="comparison-grid">
            <div class="comparison-card conventional">
                <p class="card-label">Standard Approach</p>
                <p class="card-text">"Take a probiotic for your bloating and eat more fiber for your digestion."</p>
            </div>
            <div class="comparison-card functional">
                <p class="card-label">A.G.E.L.E.S.S. Longevity Approach</p>
                <p class="card-text">"We are using targeted Akkermansia and Urolithin A to optimize your gut-mitochondria axis, reduce systemic inflammaging, and improve metabolic flexibility."</p>
            </div>
        </div>

        <p>Always correlate gut interventions with <b>"A" (Assess Biomarkers)</b>. If a client's <i>GlycanAge</i> (from Lesson 12.2) is high, it is a direct signal that the gut-mediated inflammatory state is accelerating biological aging. Conversely, successful gut intervention should result in a lower biological age on epigenetic clocks over 6-12 months.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of targeted microbiome interventions.</p>

            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why is <i>Akkermansia muciniphila</i> considered a "paradoxical" bacterium in the gut?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It consumes the host's mucus layer (mucophagy), but this action stimulates the goblet cells to produce more mucus, resulting in a thicker, healthier gut barrier and reduced intestinal permeability.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">What is the primary epigenetic mechanism by which Butyrate influences longevity genes?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Butyrate acts as a Histone Deacetylase (HDAC) inhibitor. By inhibiting these enzymes, it promotes a more open chromatin structure, allowing for the expression of anti-inflammatory and mitochondrial-protective genes.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><b>Akkermansia is Essential:</b> Low levels are strongly correlated with obesity, T2D, and accelerated aging. Supplementation or prebiotic support (polyphenols) is a primary longevity intervention.</li>
                <li><b>SCFAs are Epigenetic Switches:</b> Butyrate isn't just fuel for the gut; it's an HDAC inhibitor that regulates systemic inflammation and mitochondrial health.</li>
                <li><b>Postbiotics Bypass Inefficiency:</b> Supplementing with Urolithin A ensures the benefits of mitophagy even in the 60% of people who cannot produce it naturally from food.</li>
                <li><b>Precision Over Generalization:</b> Tailor fiber types (Prebiotics) to the specific microbial needs of the client rather than using a one-size-fits-all fiber approach.</li>
                <li><b>Continuous Loop:</b> Use the A.G.E.L.E.S.S. Protocolâ„¢ to link gut health (G) to biomarkers (A) and supplement strategy (S) for a holistic longevity plan.</li>
            </ul>
        </div>

        <div class="references-box">
            <p style="font-weight: 600; color: #333; margin-bottom: 15px;">References & Further Reading</p>
            <ol>
                <li>Depommier et al. (2019). "Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study." <i>Nature Medicine</i>.</li>
                <li>Singh et al. (2022). "Urolithin A improves muscle strength and exercise performance in middle-aged adults." <i>JAMA Network Open</i>.</li>
                <li>Cani et al. (2022). "Akkermansia muciniphila: from discovery to therapeutic applications in the context of metabolic diseases." <i>Gut</i>.</li>
                <li>Belzer et al. (2017). "Microbial Metabolic Networks at the Mucosal Interface: The Role of Akkermansia muciniphila." <i>Journal of Molecular Biology</i>.</li>
                <li>Sivaprakasam et al. (2016). "Short-chain fatty acids and cellular signaling: The G protein-coupled receptor and histone deacetylase connection." <i>Pharmacological Research</i>.</li>
                <li>D'Amico et al. (2021). "The impact of the gut microbiome on muscle mass and physical function in older adults." <i>The Lancet Healthy Longevity</i>.</li>
            </ol>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Anti-Aging & Longevity Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. The A.G.E.L.E.S.S. Longevity Protocolâ„¢ is a proprietary trademark.</p>
        </footer>
    </div>
</body>

</html>